MILESTONE PHARMACEUTICALS IN (MIST)
CA59935V1076 - Common Stock
ChartMill assigns a Buy % Consensus number of 80% to MIST. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 10.71. This target is 595.45% above the current price.
MIST was analyzed by 10 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about MIST.
In the previous month the buy percentage consensus was at a similar level.
MIST was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-05 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-02-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-12-27 | TD Cowen | Maintains | Outperform -> Outperform |
| 2023-08-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-20 | Jefferies | Downgrade | Buy -> Hold |
| 2023-05-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-04-12 | Oppenheimer | Maintains | Outperform |
| 2023-03-30 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-09 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-11-14 | HC Wainwright & Co. | Maintains | Buy |
| 2022-04-22 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2021-03-05 | HC Wainwright & Co. | Initiate | Buy |